Crestcare Diagnostics And Multispeciality Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-11-2024
- Paid Up Capital ₹ 1.00 M
as on 09-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 M
as on 09-11-2024
- Revenue 22.63%
(FY 2023)
- Profit -57.66%
(FY 2023)
- Ebitda 94.08%
(FY 2023)
- Net Worth 3.60%
(FY 2023)
- Total Assets 9.49%
(FY 2023)
About Crestcare Diagnostics And Multispeciality Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.50 M.
Rameez Rasool and Ajaz Shah serve as directors at the Company.
- CIN/LLPIN
U85100JK2020PTC011864
- Company No.
011864
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Srinagar, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crestcare Diagnostics And Multispeciality Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameez Rasool  | Director | 04-Nov-2020 | Current |
| Ajaz Shah | Director | 24-May-2023 | Current |
Financial Performance of Crestcare Diagnostics And Multispeciality Centre.
Crestcare Diagnostics And Multispeciality Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.63% increase. The company also saw a substantial fall in profitability, with a 57.66% decrease in profit. The company's net worth moved up by a moderate rise of 3.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crestcare Diagnostics And Multispeciality Centre?
Unlock access to Crestcare Diagnostics And Multispeciality Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Aug 2023 | ₹9.50 M | Open |
How Many Employees Work at Crestcare Diagnostics And Multispeciality Centre?
Crestcare Diagnostics And Multispeciality Centre has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crestcare Diagnostics And Multispeciality Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crestcare Diagnostics And Multispeciality Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
